Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection

The new coronavirus SARS-CoV-2 was identified to be responsible for the COVID-19 pandemic. There are striking differences in the response to infection, some people develop no or mild symptoms, while other outcomes are severe of even fatal. For those COVID-19 patients who require hospitalization, pro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fuchs Dietmar, Gisslen Magnus
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2021
Materias:
Acceso en línea:https://doaj.org/article/d25e83eb157a4f23b6dec54a3649c65b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d25e83eb157a4f23b6dec54a3649c65b
record_format dspace
spelling oai:doaj.org-article:d25e83eb157a4f23b6dec54a3649c65b2021-12-05T14:11:02ZLaboratory diagnostic value of neopterin measurements in patients with COVID-19 infection0933-48072195-472010.1515/pteridines-2021-0001https://doaj.org/article/d25e83eb157a4f23b6dec54a3649c65b2021-01-01T00:00:00Zhttps://doi.org/10.1515/pteridines-2021-0001https://doaj.org/toc/0933-4807https://doaj.org/toc/2195-4720The new coronavirus SARS-CoV-2 was identified to be responsible for the COVID-19 pandemic. There are striking differences in the response to infection, some people develop no or mild symptoms, while other outcomes are severe of even fatal. For those COVID-19 patients who require hospitalization, prognostic markers could help clinicians to identify patients with a poor outcome early. The serum levels of the immune activation marker neopterin have already been shown to be of prognostic value in patients with SARS-CoV-1 and a similar pattern can be observed for SARS-CoV-2. This comment discusses the biochemical circuits that support the clinical value of neopterin measurements in COVID-19 patients.Fuchs DietmarGisslen MagnusDe Gruyterarticlecovid-19neopterinlaboratory diagnosticCrystallographyQD901-999ENPteridines, Vol 32, Iss 1, Pp 1-4 (2021)
institution DOAJ
collection DOAJ
language EN
topic covid-19
neopterin
laboratory diagnostic
Crystallography
QD901-999
spellingShingle covid-19
neopterin
laboratory diagnostic
Crystallography
QD901-999
Fuchs Dietmar
Gisslen Magnus
Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection
description The new coronavirus SARS-CoV-2 was identified to be responsible for the COVID-19 pandemic. There are striking differences in the response to infection, some people develop no or mild symptoms, while other outcomes are severe of even fatal. For those COVID-19 patients who require hospitalization, prognostic markers could help clinicians to identify patients with a poor outcome early. The serum levels of the immune activation marker neopterin have already been shown to be of prognostic value in patients with SARS-CoV-1 and a similar pattern can be observed for SARS-CoV-2. This comment discusses the biochemical circuits that support the clinical value of neopterin measurements in COVID-19 patients.
format article
author Fuchs Dietmar
Gisslen Magnus
author_facet Fuchs Dietmar
Gisslen Magnus
author_sort Fuchs Dietmar
title Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection
title_short Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection
title_full Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection
title_fullStr Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection
title_full_unstemmed Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection
title_sort laboratory diagnostic value of neopterin measurements in patients with covid-19 infection
publisher De Gruyter
publishDate 2021
url https://doaj.org/article/d25e83eb157a4f23b6dec54a3649c65b
work_keys_str_mv AT fuchsdietmar laboratorydiagnosticvalueofneopterinmeasurementsinpatientswithcovid19infection
AT gisslenmagnus laboratorydiagnosticvalueofneopterinmeasurementsinpatientswithcovid19infection
_version_ 1718371504861741056